Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.

INTRODUCTION:FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of recent pill use. We conducted a follow-up study to identify, among other topics, participan...

Full description

Bibliographic Details
Main Authors: Amy Corneli, Brian Perry, Kawango Agot, Khatija Ahmed, Fulufhelo Malamatsho, Lut Van Damme
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4395082?pdf=render